| Bioactivity | KSPWFTTL TFA is an immunodominant Kb-restricted epitope from the p15E transmembrane protein. KSPWFTTL TFA can restore susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes[1][2]. | ||||||
| Invitro | KSPWFTTL TFA is derived from the retroviral p15 TM envelope protein. The cytolytic T-lymphocyte (CTL)-insusceptible, variant cl.18-5 clonal line, after pulsed with the KSPWFTTL TFA peptide, becomes susceptible to lysis by antiviral CTL[2]. | ||||||
| Name | KSPWFTTL TFA | ||||||
| Sequence | Lys-Ser-Pro-Trp-Phe-Thr-Thr-Leu | ||||||
| Shortening | KSPWFTTL | ||||||
| Formula | C50H71F3N10O14 | ||||||
| Molar Mass | 1093.15 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |